Chargement en cours...
The In Vitro Evaluation of Tigecycline and the In Vivo Evaluation of RPX-978 (0.5% Tigecycline) as an Ocular Antibiotic
Purpose: The goals of the current study were to determine the in vitro antibacterial activity of tigecycline against multiple clinically relevant ocular pathogens and to evaluate the in vivo ocular tolerability and efficacy of 0.5% tigecycline in a methicillin-resistant Staphylococcus aureus (MRSA)...
Enregistré dans:
| Publié dans: | J Ocul Pharmacol Ther |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Mary Ann Liebert, Inc.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4779973/ https://ncbi.nlm.nih.gov/pubmed/26545167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jop.2015.0095 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|